Lower extremity artery disease in patients with type 2 diabetes

被引:30
作者
Buso, Giacomo [1 ]
Aboyans, Victor [2 ,3 ]
Mazzolai, Lucia [1 ]
机构
[1] CHU Vaudois, Dept Angiol, Ch Mt Paisible 18, CH-1011 Lausanne, Switzerland
[2] Dupuytren Univ Hosp, Dept Cardiol, Limoges, France
[3] Inserm 1098, Sch Med, Paris, France
关键词
Lower extremity artery disease; diabetes; cardiovascular prevention; MAGNETIC-RESONANCE ANGIOGRAPHY; ENDOTHELIAL PROGENITOR CELLS; ANKLE-BRACHIAL INDEX; CARDIOVASCULAR OUTCOMES; RISK-FACTORS; VASCULAR-DISEASE; STATIN THERAPY; FOLLOW-UP; METAANALYSIS; PREVALENCE;
D O I
10.1177/2047487319880044
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Among all peripheral arterial diseases, lower extremity arterial disease is a serious condition in subjects with type 2 diabetes mellitus, associated with important disability, cardiovascular risk, and socio-economic burden. Patients with both conditions generally display poorer prognosis of affected limbs compared with non-diabetic subjects, leading to increased rates of adverse limb events including amputations. Nonetheless, awareness on lower extremity arterial disease remains somehow suboptimal in the diabetic population, partly related to an atypical clinical presentation in several cases. A regular and appropriate screening for lower extremity arterial disease in patients suffering from type 2 diabetes mellitus is therefore recommended. Affected subjects should receive optimal medical treatment including careful management of the different cardiovascular risk factors through a healthy lifestyle, a regular and structured physical activity, the administration of lipid-lowering, antidiabetic drugs, and (when indicated) antihypertensive and antithrombotic drugs. This review aims to outline current evidence about lower extremity arterial disease in patients with type 2 diabetes mellitus, in order to elucidate its epidemiology, pathophysiology, screening and diagnosis, and management options.
引用
收藏
页码:114 / 124
页数:11
相关论文
共 58 条
[1]   2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS) [J].
Aboyans, Victor ;
Ricco, Jean-Baptiste ;
Bartelink, Marie-Louise E. L. ;
Bjorck, Martin ;
Brodmann, Marianne ;
Cohnert, Tina ;
Collet, Jean-Philippe ;
Czerny, Martin ;
De Carlo, Marco ;
Debus, Sebastian ;
Espinola-Klein, Christine ;
Kahan, Thomas ;
Kownator, Serge ;
Mazzolai, Lucia ;
Naylor, A. Ross ;
Roffi, Marco ;
Roether, Joachim ;
Sprynger, Muriel ;
Tendera, Michal ;
Tepe, Gunnar ;
Venermo, Maarit ;
Vlachopoulos, Charalambos ;
Desormais, Ileana .
EUROPEAN HEART JOURNAL, 2018, 39 (09) :763-+
[2]   Measurement and Interpretation of the Ankle-Brachial Index A Scientific Statement From the American Heart Association [J].
Aboyans, Victor ;
Criqui, Michael H. ;
Abraham, Pierre ;
Allison, Matthew A. ;
Creager, Mark A. ;
Diehm, Curt ;
Fowkes, F. Gerry R. ;
Hiatt, William R. ;
Joensson, Bjoern ;
Lacroix, Philippe ;
Marin, Benoit ;
McDermott, Mary M. ;
Norgren, Lars ;
Pande, Reena L. ;
Preux, Pierre-Marie ;
Stoffers, H. E. ;
Treat-Jacobson, Diane .
CIRCULATION, 2012, 126 (24) :2890-+
[3]   Physical exercise and risk of arterial hypertension and diabetes mellitus. Let's move, it is never too late [J].
Abrignani, Maurizio G. .
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2018, 25 (10) :1063-1064
[4]   UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes [J].
Adler, AI ;
Stevens, RJ ;
Neil, A ;
Stratton, IM ;
Boulton, AJM ;
Holman, RR .
DIABETES CARE, 2002, 25 (05) :894-899
[5]   Achievement of Goals in U.S. Diabetes Care, 1999-2010 [J].
Ali, Mohammed K. ;
Bullard, Kai McKeever ;
Saaddine, Jinan B. ;
Cowie, Catherine C. ;
Imperatore, Giuseppina ;
Gregg, Edward W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (17) :1613-1624
[6]   Favorable Effects of Insulin Sensitizers Pertinent to Peripheral Arterial Disease in Type 2 Diabetes Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial [J].
Althouse, Andrew D. ;
Abbott, J. Dawn ;
Sutton-Tyrrell, Kim ;
Forker, Alan D. ;
Lombardero, Manuel S. ;
Buitron, L. Virginia ;
Pena-Sing, Ivan ;
Tardif, Jean-Claude ;
Brooks, Maria Mori .
DIABETES CARE, 2013, 36 (10) :3269-3275
[7]   Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial [J].
Anand, Sonia S. ;
Bosch, Jackie ;
Eikelboom, John W. ;
Connolly, Stuart J. ;
Diaz, Rafael ;
Widimsky, Peter ;
Aboyans, Victor ;
Alings, Marco ;
Kakkar, Ajay K. ;
Keltai, Katalin ;
Maggioni, Aldo P. ;
Lewis, Basil S. ;
Stoerk, Stefan ;
Zhu, Jun ;
Lopez-Jaramillo, Patricio ;
O'Donnell, Martin ;
Commerford, Patrick J. ;
Vinereanu, Dragos ;
Pogosova, Nana ;
Ryden, Lars ;
Fox, Keith A. A. ;
Bhatt, Deepak L. ;
Misselwitz, Frank ;
Varigos, John D. ;
Vanassche, Thomas ;
Avezum, Alvaro A. ;
Chen, Edmond ;
Branch, Kelley ;
Leong, Darryl P. ;
Bangdiwala, Shrikant I. ;
Hart, Robert G. ;
Yusuf, Salim .
LANCET, 2018, 391 (10117) :219-229
[8]   Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia [J].
Armstrong, Ehrin J. ;
Chen, Debbie C. ;
Singh, Gagan D. ;
Amsterdam, Ezra A. ;
Laird, John R. .
VASCULAR MEDICINE, 2015, 20 (03) :237-244
[9]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[10]   Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes [J].
Basta, G ;
Schmidt, AM ;
De Caterina, R .
CARDIOVASCULAR RESEARCH, 2004, 63 (04) :582-592